A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of a Good Practice focusing on the implementation of multi-sectoral care pathways using emerging technologies with real life data in rhinitis and asthma multi-morbidity. The European Union Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) has developed a checklist of 28 items for the evaluation of Good Practices. SUNFRAIL (Reference Sites Network for Prevention and Care of Frailty and Chronic Conditions in community dwelling persons of EU Countries), a European Union project, assessed whether MASK is in line with the 28 items of JA-CHRODIS. A short summary was proposed for each item and 18 experts, all members of ARIA and SUNFRAIL from 12 countries, assessed the 28 items using a Survey Monkey-based questionnaire. A visual analogue scale (VAS) from 0 (strongly disagree) to 100 (strongly agree) was used. Agreement equal or over 75% was observed for 14 items (50%). MASK is following the JA-CHRODIS recommendations for the evaluation of Good Practices.

Academic Centre of Primary Care University of Aberdeen Aberdeen UK

Allergist Reims France

Allergologia S Medicina Interna Hospital Vall d'Hebron Barcelona Spain

Allergology Department Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand Trousseau Paris France

Allergy and Clinical Immunology Department Hospital CUF Descobertas Lisbon Portugal

Allergy and Immunology Department Santa Isabel Buenos Aires Argentina

Allergy and Respiratory Diseases IRCCS San Martino Hospital IST University of Genoa Genoa Italy

Allergy and Respiratory Research Group Usher Institute of Population Health Sciences and Informatics University of Edinburgh Edinburgh UK

Allergy Department 2nd Pediatric Clinic Athens General Children's Hospital P and A Kyriakou University of Athens Athens 11527 Greece

Allergy Unit CUF Porto Instituto and Hospital Porto Portugal

Argentina Center for Allergy and Immunology Alassia Children's Hospital Santa Fe Santa Fe Argentina

Asthma UK Centre for Applied Research Centre of Medical Informatics Usher Institute of Population Health Sciences and Informatics The University of Edinburgh Edinburgh UK

Caisse Assurance Retraite et Santé Au Travail Languedoc Roussillon 34000 Montpellier France

Center for Health Technology and Services Research CINTESIS Faculdade de Medicina Universidade do Porto Porto Portugal

Center for Pediatrics and Child Health Institute of Human Development Royal Manchester Children's Hospital University of Manchester Manchester M13 9WL UK

Center for Rhinology and Allergology Wiesbaden Germany

Centre for Research in Environmental Epidemiology ISGLoBAL Barcelona Spain

CHRU de Montpellier Sorbonne Universités UPMC Paris 06 UMR S 1136 IPLESP Equipe EPAR 75013 Paris France

CHU Grenoble La Tronche France

CHU Montpellier 371 Avenue du Doyen Gaston Giraud 34295 Montpellier Cedex 5 France

CIBER Epidemiología y Salud Pública Madrid Spain

CIRFF Federico 2 University Naples Italy

Clinic of Infectious Chest Diseases Dermatology and Allergology Vilnius University Vilnius Lithuania

Clínica de Alergia Asma y Pediatría Hospital Médica Sur Mexico Mexico

Clinical and Experimental Respiratory Immunoallergy ENT Department Hospital Clínic IDIBAPS CIBERES Universitat de Barcelona Barcelona Spain

Comprehensive Allergy Centre Charité Department of Dermatology and Allergy Charité Universitätsmedizin Berlin Berlin Germany

Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site Montpellier France

Department of Allergy Immunology and Respiratory Medicine Alfred Hospital and Central Clinical School Monash University Melbourne VIC Australia

Department of Chest Medicine Centre Hospitalier Universitaire UCL Namur Université Catholique de Louvain Yvoir Belgium

Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Stockholm Sweden

Department of Dermatology and Allergy Centre Odense University Hospital Odense Denmark

Department of ENT Medical University of Graz Graz Austria

Department of Geriatrics Medical University of Lodz Healthy Ageing Research Centre Lodz Poland

Department of Health Social Services and Public Safety Belfast Northern Ireland UK

Department of Immunology Monash University Melbourne VIC Australia

Department of Immunology Rheumatology and Allergy Medical University of Lodz and HARC Lodz Poland

Department of Medicine Surgery and Dentistry Scuola Medica Salernitana University of Salerno Salerno Italy

Department of Otorhinolaryngology Academic Medical Centre Amsterdam The Netherlands

Department of Pediatric Imperial College London London UK

Department of Pediatrics and Child Health Department of Immunology Faculty of Medicine University of Manitoba Winnipeg Manitoba Canada

Department of Pediatrics Medical School Federal University of Minas Gerais Belo Horizonte Brazil

Department of Prevention of Envinronmental Hazards and Allergology Medical University of Warsaw Warsaw Poland

Department of Public Health and Primary Care Leiden University Medical Center Leiden The Netherlands

Department of Pulmonary Diseases Cerrahpasa Faculty of Medicine Istanbul University Istanbul Turkey

Department of Pulmonary Medicine CHU Sart Tilman Liege Belgium

Department of Pulmonology Celal Bayar University Manisa Turkey

Department of Respiratory Diseases Montpellier University Hospital Montpellier France

Department of Respiratory Diseases Odense University Hospital Odense Denmark

Department of Respiratory Medicine and Allergology University Hospital Lund Sweden

Department of Respiratory Medicine Ghent University Hospital Ghent Belgium

Division for Health Innovation Campania Region and Federico 2 University Hospital Naples Naples Italy

Division of Internal Medicine Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland

EC CNECT H2 European Commission Brussels Belgium

EFA European Federation of Allergy and Airways Diseases Patients' Associations Brussels Belgium

EIP AHA Reference Site Coimbra Portugal

ENT Department Medical Faculty Eskisehir Osmangazi University Eskisehir Turkey

EPAR U707 INSERM Paris and EPAR UMR S UPMC Paris 6 Paris France

Faculty of Medicine Transylvania University Brasov Romania

GARD Chairman Geneva Switzerland

GARD Executive Committee Manisa Turkey

GARD Executive Committee Salvador Brazil

Gesundheitsregion KölnBonn HRCB Projekt GmbH Kohln Germany

Global Allergy and Asthma European Network Berlin Germany

Global Allergy and Asthma Platform GAAPP Altgasse 8 10 1130 Vienna Austria

Hôpital de la Malbaie Quebec City Canada

IMIM Barcelona Spain

Imunoalergologia Centro Hospitalar Universitário de Coimbra and Faculty of Medicine University of Coimbra Coimbra Portugal

INSERM U 1168 VIMA Ageing and Chronic Diseases Epidemiological and Public Health Approaches Villejuif Université Versailles St Quentin en Yvelines UMR S 1168 Montigny le Bretonneux France

Institute for Clinical Epidemiology and Biometry University of Wuerzburg Würzburg Germany

Institute of Biomedical Imaging and Life Sciences Faculty of Medicine University of Coimbra Coimbra Portugal

Institute of Health Policy and Management iBMG Erasmus University Rotterdam The Netherlands

Institute of Medical Statistics Informatics and Epidemiology Medical Faculty University of Cologne Cologne Germany

Institute of Social Medicine Epidemiology and Health Economics Charité Universitätsmedizin Berlin Berlin Germany

iQ4U Consultants Ltd London UK

Kronikgune International Centre of Excellence in Chronicity Research Barakaldo Bizkaia Bilbao Spain

Kyomed Montpellier France

Laboratoire de Pharmacologie Respiratoire UPRES EA220 Pôle des Maladies Respiratoires Hôpital Foch Suresnes Université Versailles Saint Quentin Versailles France

Laboratory of Clinical Immunology Department of Microbiology and Immunology KU Leuven Louvain Belgium

Laval's University Quebec City Canada

Libra Foundation Buenos Aires Argentina

Life and Health Sciences Research Institute School of Health Sciences University of Minho Braga Portugal

Medical Communications Consultant MedScript Ltd Dundalk Co Louth Ireland

Observational and Pragmatic Research Institute Singapore Singapore

Optimum Patient Care Cambridge UK

Peercode DV Gerdermalsen The Netherlands

Personalized Medicine Clinic Asthma and Allergy Humanitas University Humanitas Research Hospital Rozzano Milan Italy

Pneumology and Allergy Department Hospital Clínic Clinical and Experimental Respiratory Immunoallergy IDIBAPS CIBERES University of Barcelona Barcelona Spain

ProAR Nucleo de Excelencia em Asma Federal University of Bahia Salvador Brazil

Public Health Agency Northern Ireland Belfast UK

Queen's University Belfast Belfast Northern Ireland UK

Regional Ministry of Health of Andalusia Seville Spain

Regione Emilia Romagna Agenzia Sanitaria e Sociale Reference Site of the European Innovation Partnership on Healthy and Active Ageing Bologna Italy

Sachs' Children and Youth Hospital Södersjukhuset Stockholm and Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

Service de Pneumologie UMR INSERM UMR1087 and CNR 6291 l'institut du thorax University of Nantes Nantes France

Skin and Allergy Hospital Helsinki University Hospital Helsinki Finland

Unit of Geriatric Immunoallergology University of Bari Medical School Bari Italy

Universitat Pompeu Fabra Barcelona Spain

University Hospital Olomouc National eHealth Centre Olomouc Czech Republic

University Hospital Olomouc Olomouc Czech Republic

UPMC Univ Paris 06 UMR_S 1136 Institut Pierre Louis d'Epidémiologie et de Santé Publique Equipe EPAR Sorbonne Universités 75013 Paris France

Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium

Woolcock Institute of Medical Research University of Sydney and Sydney Local Health District Glebe NSW Australia

Zobrazit více v PubMed

Bousquet J, Michel J, Standberg T, Crooks G, Iakovidis I, Gomez M. The European innovation partnership on active and healthy ageing: the european geriatric medicine introduces the EIP on AHA column. Eur Geriatr Med. 2014;5(6):361–362. doi: 10.1016/j.eurger.2014.09.010. DOI

Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs) Eur Respir J. 2014;44(2):304–323. doi: 10.1183/09031936.00014614. PubMed DOI

Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J. 2016;47(4):1028–1033. doi: 10.1183/13993003.01856-2015. PubMed DOI

Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007;62(3):216–223. doi: 10.1111/j.1398-9995.2007.01307.x. PubMed DOI

Bousquet J, Bourquin C, Augé P, Domy P, Bringer J, Camuzat T, et al. MACVIA-LR reference site of the european innovation partnership on active and healthy ageing. Eur GeriatrMed. 2014;5(6):406–415. doi: 10.1016/j.eurger.2014.07.013. DOI

Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147–S334. doi: 10.1067/mai.2001.118891. PubMed DOI

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy. 2008;63(Suppl 86):8–160. doi: 10.1111/j.1398-9995.2007.01620.x. PubMed DOI

Bousquet J, Schunemann HJ, Zuberbier T, Bachert C, Baena-Cagnani CE, Bousquet PJ, et al. Development and implementation of guidelines in allergic rhinitis—an ARIA-GA2LEN paper. Allergy. 2010;65(10):1212–1221. doi: 10.1111/j.1398-9995.2010.02439.x. PubMed DOI

Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64(5):669–677. doi: 10.1111/j.1398-9995.2009.01973.x. PubMed DOI

Brozek JL, Akl EA, Compalati E, Kreis J, Terracciano L, Fiocchi A, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy. 2011;66(5):588–595. doi: 10.1111/j.1398-9995.2010.02530.x. PubMed DOI

Brozek JL, Akl EA, Jaeschke R, Lang DM, Bossuyt P, Glasziou P, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy. 2009;64(8):1109–1116. doi: 10.1111/j.1398-9995.2009.02083.x. PubMed DOI

Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, Rasi G, van Wijk RG, et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy. 2008;63(1):38–46. doi: 10.1111/j.1398-9995.2007.01560.x. PubMed DOI

Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466–476. doi: 10.1016/j.jaci.2010.06.047. PubMed DOI

Padjas A, Kehar R, Aleem S, Mejza F, Bousquet J, Schunemann HJ, et al. Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study. J Allergy Clin Immunol. 2014;133(3):777–83e4. PubMed

Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015;70(11):1372–1392. doi: 10.1111/all.12686. PubMed DOI

Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, et al. ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6:47. doi: 10.1186/s13601-016-0137-4. PubMed DOI PMC

Bourret R, Bousquet JJ, Mercier J, Camuzat T, Bedbrook A, Demoly P, et al. MASK rhinitis, a single tool for integrated care pathways in allergic rhinitis. World Hosp Health Serv. 2015;51(3):36–39. PubMed

Hellings PW, Muraro A, Fokkens W, Mullol J, Bachert C, Canonica GW, et al. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015;5:36. doi: 10.1186/s13601-015-0080-9. PubMed DOI PMC

Klimek L, Bergmann K, Biederman T, Bousquet J, Hellings P, et al. Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in allergic rhinitis in everyday health care. Position Paper of the German Society of Allergology. Allergo J Int. 2017;26(1):16–2. PubMed PMC

Bousquet J, Agache I, Anto JM, Bergmann KC, Bachert C, Annesi-Maesano I, et al. Google Trends terms reporting rhinitis and related topics differ in European countries. Allergy. 2017;72(8):1261–6. doi:10.1111/all.13137. PubMed

Bousquet J, O’Hehir RE, Anto JM, D’Amato G, Mosges R, Hellings PW, et al. Assessment of thunderstorm-induced asthma using Google Trends. J Allergy Clin Immunol. 2017;140(3):891–3.e7. doi:10.1016/j.jaci.2017.04.042. PubMed

Konig HH, Bernert S, Angermeyer MC, Matschinger H, Martinez M, Vilagut G, et al. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire. Med Care. 2009;47(2):255–261. doi: 10.1097/MLR.0b013e318184759e. PubMed DOI

Smith AF, Pitt AD, Rodruiguez AE, Alio JL, Marti N, Teus M, et al. The economic and quality of life impact of seasonal allergic conjunctivitis in a Spanish setting. Ophthalmic Epidemiol. 2005;12(4):233–242. doi: 10.1080/09286580590967781. PubMed DOI

Onder G, Palmer K, Navickas R, Jureviciene E, Mammarella F, Strandzheva M, et al. Time to face the challenge of multimorbidity. A European perspective from the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS) Eur J Intern Med. 2015;26(3):157–159. doi: 10.1016/j.ejim.2015.02.020. PubMed DOI

Bousquet J, Tanasescu CC, Camuzat T, Anto JM, Blasi F, Neou A, et al. Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliament. Allergy. 2013;68(5):555–561. doi: 10.1111/all.12115. PubMed DOI

Bousquet J, Agache I, Aliberti MR, Angles R, Annesi-Maesano I, Anto JM, et al. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA)—Reference Site Twinning (EIP on AHA). Allergy. 2017. PubMed

Selroos O, Kupczyk M, Kuna P, Lacwik P, Bousquet J, Brennan D, et al. National and regional asthma programmes in Europe. Eur Respir Rev. 2015;24(137):474–483. doi: 10.1183/16000617.00008114. PubMed DOI PMC

Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings. Cancer, diabetes, heart disease and stroke, chronic respiratory disease. WHO, editor 2010.

Fairall L, Bateman E, Cornick R, Faris G, Timmerman W, Folb N, et al. Innovating to improve primary care in less developed countries: towards a global model, BMC innovations. BMJ Innov. 2015;1(4):196–203. doi: 10.1136/bmjinnov-2015-000045. PubMed DOI PMC

Samolinski B, Fronczak A, Wlodarczyk A, Bousquet J. Council of the European Union conclusions on chronic respiratory diseases in children. Lancet. 2012;379(9822):e45–e46. doi: 10.1016/S0140-6736(12)60514-5. PubMed DOI

Samolinski B, Fronczak A, Kuna P, Akdis CA, Anto JM, Bialoszewski AZ, et al. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy. 2012;67(6):726–731. doi: 10.1111/j.1398-9995.2012.02822.x. PubMed DOI PMC

WHO. Healthy settings. World Health Organization. http://www.whoint/healthy_settings/en/. 2013.

Dooris M. Healthy settings: challenges to generating evidence of effectiveness. Health Promot Int. 2006;21(1):55–65. doi: 10.1093/heapro/dai030. PubMed DOI

Bousquet J, Bewick M, Arnavielhe S, Mathieu-Dupas E, Murray R, Bedbrook A, et al. Work productivity in rhinitis using cell phones: the MASK pilot study. Allergy. 2017;72(10):1475–84. doi:10.1111/all.13177. PubMed

ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma. Allergy. 2004;59(4):373–87. PubMed

Bousquet J, Schunemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012;130(5):1049–1062. doi: 10.1016/j.jaci.2012.07.053. PubMed DOI

Bousquet J, Khaltaev N. Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. World Health Organization. ISBN 978 92 4 156346 8. 2007.

Bousquet J, Burney PG, Zuberbier T, Cauwenberge PV, Akdis CA, Bindslev-Jensen C, et al. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’. Allergy. 2009;64(7):969–977. doi: 10.1111/j.1398-9995.2009.02059.x. PubMed DOI

Hellings PW, Akdis CA, Bachert C, Bousquet J, Pugin B, Adriaensen G, et al. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis. Rhinology. 2017. PubMed

Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis—an EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017. PubMed

Bousquet J, Anto JM, Akdis M, Auffray C, Keil T, Momas I, et al. Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story. Allergy. 2016. PubMed PMC

Anto JM, Bousquet J, Akdis M, Auffray C, Keil T, Momas I, et al. Mechanisms of the Development of Allergy (MeDALL): introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol. 2017;139(2):388–399. doi: 10.1016/j.jaci.2016.12.940. PubMed DOI

Bousquet J, Anto JM, Just J, Keil T, Siroux V, Wickman M. The multimorbid polysensitized phenotype is associated with the severity of allergic diseases. J Allergy Clin Immunol. 2017. PubMed

Bousquet J, Bewick M, Cano A, Eklund P, Fico G, Goswami N, et al. building bridges for innovation in ageing: synergies between Action Groups of the EIP on AHA. J Nutr Health Aging. 2017;21(1):92–104. doi: 10.1007/s12603-016-0803-1. PubMed DOI

Lodrup Carlsen KC, Haahtela T, Carlsen KH, Smith A, Bjerke M, Wickman M, et al. Integrated Allergy and Asthma Prevention and Care: report of the MeDALL/AIRWAYS ICPs Meeting at the Ministry of Health and Care Services, Oslo. Norway. Int Arch Allergy Immunol. 2015;167(1):57–64. doi: 10.1159/000431359. PubMed DOI

Haahtela T, Valovirta E, Bousquet J, Makela M, and the Allergy Programme Steering G. The Finnish Allergy Programme 2008–2018 works. Eur Respir J. 2017;49(6):1700470. doi:10.1183/13993003.00470-2017. PubMed

Bousquet J, Schunemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367–74e2. PubMed

Bousquet J, Kiley J, Bateman ED, Viegi G, Cruz AA, Khaltaev N, et al. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J. 2010;36(5):995–1001. doi: 10.1183/09031936.00012610. PubMed DOI

Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010;126(5):926–938. doi: 10.1016/j.jaci.2010.07.019. PubMed DOI

Yorgancioglu A, Cruz AA, Bousquet J, Khaltaev N, Mendis S, Chuchalin A, et al. The global alliance against respiratory diseases (GARD) country report. Prim Care Respir J. 2014;23(1):98–101. doi: 10.4104/pcrj.2014.00014. PubMed DOI PMC

Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, et al. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) Clin Transl Allergy. 2016;6:29. doi: 10.1186/s13601-016-0116-9. PubMed DOI PMC

Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, Fokkens W, Kemp J, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy. 2007;62(Suppl 84):1–41. doi: 10.1111/j.1398-9995.2007.01551.x. PubMed DOI

Yorgancioglu AA, Kalayci O, Cingi C, Gemicioglu B, Kalyoncu AF, Agache I, et al. ARIA 2016 executive summary: integrated care pathways for predictive medicine across the life cycle. Tuberk Toraks. 2017;65(1):32–40. doi: 10.5578/tt.52766. PubMed DOI

Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines—2016 Revision. . J Allergy Clin Immunol. 2017;140(4):950–958. doi: 10.1016/j.jaci.2017.03.050. PubMed DOI

Bousquet J, Schunemann HJ, Bousquet PJ, Bachert C, Canonica GW, Casale TB, et al. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy. 2011;66(6):765–774. doi: 10.1111/j.1398-9995.2011.02590.x. PubMed DOI

Bousquet J, Caimmi DP, Bedbrook A, Bewick M, Hellings PW, Devillier P, et al. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy. 2017;72(6):857–865. doi: 10.1111/all.13125. PubMed DOI

Bousquet J, Anto JM, Demoly P, Schunemann HJ, Togias A, Akdis M, et al. Severe chronic allergic (and related) diseases: a uniform approach–a MeDALL–GA2LEN–ARIA position paper. Int Arch Allergy Immunol. 2012;158(3):216–231. doi: 10.1159/000332924. PubMed DOI

Bousquet J, Jorgensen C, Dauzat M, Cesario A, Camuzat T, Bourret R, et al. Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. Curr Pharm Des. 2014;20(38):5928–5944. doi: 10.2174/1381612820666140314115505. PubMed DOI

Marschang S. Health inequalities and eHealth. Report of the eHealth Stakeholder Group. Final version. 21 February 2014.. eceuropaeu/information_society/newsroom//documentcfm? 2014.

Ross J, Stevenson F, Lau R, Murray E. Exploring the challenges of implementing e-health: a protocol for an update of a systematic review of reviews. BMJ Open. 2015;5(4):e006773. doi: 10.1136/bmjopen-2014-006773. PubMed DOI PMC

Wood J. Complexity avalanche—overcoming the threat to technology adoption. 2009:ISBN: 978-0-9842130-0-9.

DiPietro NA. Methods in epidemiology: observational study designs. Pharmacotherapy. 2010;30(10):973–984. doi: 10.1592/phco.30.10.973. PubMed DOI

Yang W, Zilov A, Soewondo P, Bech OM, Sekkal F, Home PD. Observational studies: going beyond the boundaries of randomized controlled trials. Diabetes Res Clin Pract. 2010;88(Suppl 1):S3–S9. doi: 10.1016/S0168-8227(10)70002-4. PubMed DOI

Zuberbier T, Lotvall J, Simoens S, Subramanian SV, Church MK. Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review. Allergy. 2014;69(10):1275–1279. doi: 10.1111/all.12470. PubMed DOI

Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med. 1993;36(6):725–733. doi: 10.1016/0277-9536(93)90033-Z. PubMed DOI

Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol. 1994;94(2 Pt 1):182–188. doi: 10.1053/ai.1994.v94.a54939. PubMed DOI

Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1391–6. PubMed

Blanc PD, Trupin L, Eisner M, Earnest G, Katz PP, Israel L, et al. The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol. 2001;54(6):610–618. doi: 10.1016/S0895-4356(00)00349-8. PubMed DOI

Vandenplas O, D’Alpaos V, Van Brussel P. Rhinitis and its impact on work. Curr Opin Allergy Clin Immunol. 2008;8(2):145–149. doi: 10.1097/ACI.0b013e3282f63d92. PubMed DOI

Vandenplas O, Van Brussel P, D’Alpaos V, Wattiez M, Jamart J, Thimpont J. Rhinitis in subjects with work-exacerbated asthma. Respir Med. 2010;104(4):497–503. doi: 10.1016/j.rmed.2009.11.005. PubMed DOI

Hellgren J, Cervin A, Nordling S, Bergman A, Cardell LO. Allergic rhinitis and the common cold–high cost to society. Allergy. 2010;65(6):776–783. doi: 10.1111/j.1398-9995.2009.02269.x. PubMed DOI

Kakutani C, Ogino S, Ikeda H, Enomoto T. Impact of allergic rhinitis on work productivity: a pilot study. Arerugi. 2005;54(7):627–635. PubMed

Kim SY, Yoon SJ, Jo MW, Kim EJ, Kim HJ, Oh IH. Economic burden of allergic rhinitis in Korea. Am J Rhinol Allergy. 2010;24(5):e110–e113. doi: 10.2500/ajra.2010.24.3513. PubMed DOI

Marcellusi A, Viti R, Incorvaia C, Mennini FS. Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study. Recenti Prog Med. 2015;106(10):517–527. PubMed

Bousquet J, Neukirch F, Bousquet PJ, Gehano P, Klossek JM, Le Gal M, et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol. 2006;117(1):158–162. doi: 10.1016/j.jaci.2005.09.047. PubMed DOI

Virchow JC, Kay S, Demoly P, Mullol J, Canonica W, Higgins V. Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients–an observational, cross sectional study in four countries in Europe. J Med Econ. 2011;14(3):305–314. doi: 10.3111/13696998.2011.576039. PubMed DOI

Lamb CE, Ratner PH, Johnson CE, Ambegaonkar AJ, Joshi AV, Day D, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin. 2006;22(6):1203–1210. doi: 10.1185/030079906X112552. PubMed DOI

de la Hoz Caballer B, Rodriguez M, Fraj J, Cerecedo I, Antolin-Amerigo D, Colas C. Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the Cross-sectional study to evAluate work Productivity in allergic Rhinitis compared with other common dIseases (CAPRI) study. Am J Rhinol Allergy. 2012;26(5):390–394. doi: 10.2500/ajra.2012.26.3799. PubMed DOI PMC

Michie S, Yardley L, West R, Patrick K, Greaves F. Developing and evaluating digital interventions to promote behavior change in health and health care: recommendations Resulting From an International Workshop. J Med Internet Res. 2017;19(6):e232. doi: 10.2196/jmir.7126. PubMed DOI PMC

Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, et al. Unmet needs in severe chronic upper airway disease (SCUAD) J Allergy Clin Immunol. 2009;124(3):428–433. doi: 10.1016/j.jaci.2009.06.027. PubMed DOI

Bousquet PJ, Bachert C, Canonica GW, Casale TB, Mullol J, Klossek JM, et al. Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. J Allergy Clin Immunol. 2010;126(3):666–8e1-5. PubMed

Kuehl BL, Abdulnour S, O’Dell M, Kyle TK. Understanding the role of the healthcare professional in patient self-management of allergic rhinitis. SAGE Open Med. 2015;3:2050312115595822. doi: 10.1177/2050312115595822. PubMed DOI PMC

Canonica GW, Triggiani M, Senna G. 360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients. Clin Mol Allergy. 2015;13:25. doi: 10.1186/s12948-015-0029-5. PubMed DOI PMC

Meltzer EO, Farrar JR, Sennett C. Findings from an online survey assessing the burden and management of seasonal allergic rhinoconjunctivitis in US patients. J Allergy Clin Immunol Pract. 2017;5(3):779–789. PubMed

Bousquet J, Annesi-Maesano I, Carat F, Leger D, Rugina M, Pribil C, et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy. 2005;35(6):728–732. doi: 10.1111/j.1365-2222.2005.02274.x. PubMed DOI

Bousquet PJ, Devillier P, Tadmouri A, Mesbah K, Demoly P, Bousquet J. Clinical relevance of cluster analysis in phenotyping allergic rhinitis in a real-life study. Int Arch Allergy Immunol. 2015;166(3):231–240. doi: 10.1159/000381339. PubMed DOI

del Cuvillo A, Montoro J, Bartra J, Valero A, Ferrer M, Jauregui I, et al. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients—the ADRIAL cohort study. Rhinology. 2010;48(2):201–205. PubMed

Calderon MA, Demoly P, Casale T, Akdis CA, Bachert C, Bewick M, et al. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: an AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Clin Transl Allergy. 2016;6:41. doi: 10.1186/s13601-016-0131-x. PubMed DOI PMC

Bousquet J, Bourret R, Camuzat T, Auge P, Bringer J, Nogues M, et al. MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): a Success Story of the European Innovation Partnership on Active and Healthy Ageing. J Frailty Aging. 2016;5(4):233–241. PubMed

Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007;120(2):381–387. doi: 10.1016/j.jaci.2007.03.034. PubMed DOI

Cingi C, Yorgancioglu A, Cingi CC, Oguzulgen K, Muluk NB, Ulusoy S, et al. The “physician on call patient engagement trial” (POPET): measuring the impact of a mobile patient engagement application on health outcomes and quality of life in allergic rhinitis and asthma patients. Int Forum Allergy Rhinol. 2015;5(6):487–497. doi: 10.1002/alr.21468. PubMed DOI

Bousquet J, Grouse L, Zhong N. The fight against chronic respiratory diseases in the elderly: the European Innovation Partnership on Active and Healthy Aging and beyond. J Thorac Dis. 2015;7(1):108–110. PubMed PMC

Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air® approach

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

The Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing

Country activities of Global Alliance against Chronic Respiratory Diseases (GARD): focus presentations at the 11th GARD General Meeting, Brussels

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study